Brain preservation service founder Jordan Sparks softened his claim that traditional cryonics is pseudoscience to “some elements of pseudoscience” in a debate with Max More
Brain preservation service founder Jordan Sparks softened his claim that traditional cryonics is pseudoscience to “some elements of pseudoscience” in a debate with Max More
On November 17, the Cryosphere podcast released a debate between Sparks and Max More, former president of the cryonics organization Alcor. They discussed whether traditional cryonics changes in response to evidence.
Traditional cryonics, as practiced by Alcor and Cryonics Institute, replaces a deceased person's blood with a solution that inhibits ice formation, cools the body or brain, and stores it in the hope of future revival. At Sparks Brain Preservation, the brain is infused with an aldehyde that cross-links proteins and fixes the tissue's structure. At a brain preservation summit in September, Sparks said:
“Cryonics is pseudoscience. I waited a long time before using that word, but at some point you have to.”
In the debate, his starting point was that cryobiology, the study of how cold affects living cells, works while cells are alive, whereas in cryonics, he said, “the cells are dead in every case”: the brain often goes without oxygen for an hour or two, and the solution's toxicity then kills the cells. By his definition, applying cryobiology to dead cells merely imitates science. Without metabolism, tissue breaks down, and he believes that only an aldehyde introduced within the first few minutes can preserve its structure. Without it, the tissue remains unstabilized for 8–12 hours, while ice causes further damage. CT scans and electron microscopy images, Sparks added, show poor brain preservation, yet protocols remain unchanged: the feedback is ignored.
More objected to the label: “Words that harsh are better reserved for people who are actually committing fraud.” In a 2024 essay, he examines eight features of pseudoscience and argues that none applies to cryonics: it describes itself as a medical practice and updates its protocols in response to evidence. He challenged the argument about dead cells, saying that death is a gradual process and that revival by any method will require nanotechnology. In his view, cells' current lack of viability therefore does not matter as long as the structure needed for future repair survives.
More's main evidence was a preprint (a paper that has yet to undergo peer review) by cryobiologist Gregory Fahy on brain cortex biopsies from Stephen Coles, who was preserved at Alcor in 2014. The samples show no evidence of ice, and the cells are dehydrated but largely intact, despite two days of oxygen deprivation before death. Sparks regards this as a single case assessed subjectively. The authors themselves state that they are describing one brain and call the result the first direct evidence that human cryopreservation may be feasible.
Both identify preservation of brain structure as the immediate goal, but they propose different ways to assess it. Sparks argues that feedback requires a measure available now, such as structure observed under an electron microscope, because revival cannot be tested. More adds a test unavailable with chemical fixation: cell viability after rewarming. He acknowledged that direct measurements are scarce. When he led Alcor, the board refused to allow more brain sampling because “members would be very upset.” Now, according to More, about 40% of clients at the cryonics company Tomorrow Bio consent to brain microsampling for electron microscopy.
Host Max Marty asked them to agree on a shared definition of pseudoscience. Sparks replied:
“I'm not saying outright that it is pseudoscience. I'm saying that some elements of pseudoscience have crept into it.”
On which method is best, More said, “I don't know, and I don't think anyone does.” He described openness to new evidence as the opposite of a pseudoscientific approach.